Cns Pharmaceuticals Inc’s recent filing unveils that its Director Gumulka Jerzy acquired Company’s shares for reported $10000.0 on Feb 01 ’24. In the deal valued at $0.30 per share,33,333 shares were bought. As a result of this transaction, Gumulka Jerzy now holds 43,006 shares worth roughly $4300.6.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Evans Carl Anthony bought 33,333 shares, generating $10,000 in total proceeds. Upon buying the shares at $0.30, the Director now owns 33,458 shares.
Before that, Downs Christopher bought 66,666 shares. Cns Pharmaceuticals Inc shares valued at $20,000 were divested by the Chief Financial Officer at a price of $0.30 per share. As a result of the transaction, Downs Christopher now holds 103,438 shares, worth roughly $10343.800000000001.
Ladenburg Thalmann downgraded its Cns Pharmaceuticals Inc [CNSP] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating.
Price Performance Review of CNSP
On Tuesday, Cns Pharmaceuticals Inc [NASDAQ:CNSP] saw its stock fall -7.42% to $0.10. Over the last five days, the stock has lost -9.91%. Cns Pharmaceuticals Inc shares have fallen nearly -99.84% since the year began. Nevertheless, the stocks have fallen -99.90% over the past one year. While a 52-week high of $114.50 was reached on 01/02/24, a 52-week low of $0.10 was recorded on 08/16/24. SMA at 50 days reached $0.1243, while 200 days put it at $5.4388.
Levels Of Support And Resistance For CNSP Stock
The 24-hour chart illustrates a support level at 0.0983, which if violated will result in even more drops to 0.0931. On the upside, there is a resistance level at 0.1105. A further resistance level may holdings at 0.1175. The Relative Strength Index (RSI) on the 14-day chart is 37.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0085, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.00%. Stochastics %K at 17.49% indicates the stock is a buying.
How much short interest is there in Cns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Cns Pharmaceuticals Inc stocks on 2024-10-31, growing by 0.46 million shares to a total of 1.14 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.68 million shares. There was a rise of 40.32%, which implies that there is a positive sentiment for the stock.
